TCR2 Therapeutics Inc. (TCRR) has a consensus analyst rating of Hold, based on 9 analysts covering the stock. Of those, 2 recommend buying, 6 recommend holding, and 1 recommend selling.
The analyst consensus price target for TCRR is $5.00, representing a +237.8% upside from the current price of $1.48. Price targets range from a low of $5.00 to a high of $5.00.
